Sensei Biotherapeutics, Inc.
SNSE
$10.33
$2.8538.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.03M | -30.16M | -29.80M | -29.67M | -31.92M |
| Total Depreciation and Amortization | 1.03M | 1.32M | 1.32M | 1.32M | 1.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.78M | 4.65M | 4.58M | 4.88M | 5.25M |
| Change in Net Operating Assets | 79.00K | -489.00K | -1.14M | -763.00K | -2.56M |
| Cash from Operations | -24.15M | -24.67M | -25.04M | -24.23M | -27.90M |
| Capital Expenditure | -109.00K | -146.00K | -146.00K | -146.00K | -66.00K |
| Sale of Property, Plant, and Equipment | 40.00K | -- | 0.00 | 0.00 | 157.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.93M | 22.59M | 34.00M | 29.40M | 41.78M |
| Cash from Investing | 23.86M | 22.44M | 33.85M | 29.25M | 41.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -823.00K | -811.00K | -800.00K | -786.00K | -774.00K |
| Issuance of Common Stock | 34.00K | 34.00K | 38.00K | 38.00K | 48.00K |
| Repurchase of Common Stock | -3.00K | -10.00K | -262.00K | -2.61M | -10.39M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -792.00K | -787.00K | -1.02M | -3.35M | -11.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.08M | -3.02M | 7.79M | 1.67M | 2.85M |